Trial Outcomes & Findings for Unintentional Overfeeding of Formula Fed Infants (NCT NCT02701868)

NCT ID: NCT02701868

Last Updated: 2021-01-14

Results Overview

Focus groups were used to evaluate and provide recommendations to improve the reading and comprehension of powdered infant formula package preparation instructions. Five focus groups provided primary recommendations. The percentage of focus group participants reporting specific recommendations are summarized.

Recruitment status

COMPLETED

Target enrollment

171 participants

Primary outcome timeframe

Day 1

Results posted on

2021-01-14

Participant Flow

Participant milestones

Participant milestones
Measure
Phase 1
Up to 40 individuals will be recruited to participate in focus groups at Pennington Biomedical Research Center. Approximately six focus groups (each with 5-10 participants) will be conducted at the Pennington Biomedical Research Center Demonstration Kitchen over the course of approximately 3 months.
Phase 2 Standard Instructions
Up to 150 individuals who did not participate in Whoa Baby Phase 1 will be recruited for Phase 2. Up to 75 individuals will be randomized to prepare infant formula using standard instructions.
Phase 2 Modified Instructions
Up to 150 individuals who did not participate in Whoa Baby Phase 1 will be recruited for Phase 2. Up to 75 individuals will be randomized to prepare infant formula using modified instructions.
Overall Study
STARTED
21
75
75
Overall Study
COMPLETED
21
75
75
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Unintentional Overfeeding of Formula Fed Infants

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Phase 1
n=21 Participants
Up to 40 individuals will be recruited to participate in focus groups at Pennington Biomedical Research Center. Approximately six focus groups (each with 5-10 participants) will be conducted at the Pennington Biomedical Demonstration Kitchen over the course of approximately 3 months.
Phase 2 Standard Instructions
n=75 Participants
Up to 75 individuals who did not participate in Whoa Baby Phase 1 were recruited to prepare bottles using the standard infant formula preparation instructions.
Phase 2 Modified Instructions
n=75 Participants
Up to 75 individuals who did not participate in Whoa Baby Phase 1 were recruited to prepare bottles using the modified infant formula preparation instructions. The modified instructions were developed as a result of the focus groups' conditions in Phase 1.
Total
n=171 Participants
Total of all reporting groups
Age, Continuous
32.5 years
STANDARD_DEVIATION 11.7 • n=93 Participants
36.0 years
STANDARD_DEVIATION 15.8 • n=4 Participants
40.6 years
STANDARD_DEVIATION 17.6 • n=27 Participants
37.8 years
STANDARD_DEVIATION 16.5 • n=483 Participants
Sex: Female, Male
Female
17 Participants
n=93 Participants
65 Participants
n=4 Participants
59 Participants
n=27 Participants
141 Participants
n=483 Participants
Sex: Female, Male
Male
4 Participants
n=93 Participants
10 Participants
n=4 Participants
16 Participants
n=27 Participants
30 Participants
n=483 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=93 Participants
1 Participants
n=4 Participants
0 Participants
n=27 Participants
1 Participants
n=483 Participants
Race (NIH/OMB)
Asian
0 Participants
n=93 Participants
3 Participants
n=4 Participants
4 Participants
n=27 Participants
7 Participants
n=483 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
0 Participants
n=483 Participants
Race (NIH/OMB)
Black or African American
6 Participants
n=93 Participants
25 Participants
n=4 Participants
15 Participants
n=27 Participants
46 Participants
n=483 Participants
Race (NIH/OMB)
White
15 Participants
n=93 Participants
46 Participants
n=4 Participants
54 Participants
n=27 Participants
115 Participants
n=483 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
1 Participants
n=483 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
1 Participants
n=483 Participants
BMI, Continuous
26.8 kg/m^2
STANDARD_DEVIATION 8.1 • n=93 Participants
29.6 kg/m^2
STANDARD_DEVIATION 6.6 • n=4 Participants
29.5 kg/m^2
STANDARD_DEVIATION 7.9 • n=27 Participants
29.2 kg/m^2
STANDARD_DEVIATION 7.5 • n=483 Participants
Education, Categorical
High School Diploma/GED or Less
1 Participants
n=93 Participants
8 Participants
n=4 Participants
5 Participants
n=27 Participants
14 Participants
n=483 Participants
Education, Categorical
1-3 Years College
5 Participants
n=93 Participants
26 Participants
n=4 Participants
37 Participants
n=27 Participants
68 Participants
n=483 Participants
Education, Categorical
College Degree
9 Participants
n=93 Participants
25 Participants
n=4 Participants
17 Participants
n=27 Participants
51 Participants
n=483 Participants
Education, Categorical
Post-Graduate Degree
6 Participants
n=93 Participants
16 Participants
n=4 Participants
16 Participants
n=27 Participants
38 Participants
n=483 Participants
Income, Categorical
<$30,000/year
5 Participants
n=93 Participants
21 Participants
n=4 Participants
21 Participants
n=27 Participants
47 Participants
n=483 Participants
Income, Categorical
$30,000-$99,999/year
9 Participants
n=93 Participants
32 Participants
n=4 Participants
28 Participants
n=27 Participants
69 Participants
n=483 Participants
Income, Categorical
>$80,000/year
7 Participants
n=93 Participants
21 Participants
n=4 Participants
25 Participants
n=27 Participants
53 Participants
n=483 Participants
Income, Categorical
No answer
0 Participants
n=93 Participants
1 Participants
n=4 Participants
1 Participants
n=27 Participants
2 Participants
n=483 Participants

PRIMARY outcome

Timeframe: Day 1

Population: The focus groups were only completed for Phase 1 participants. This outcome measure does not apply to Phase 2 participants who did not participate in focus groups and provide infant formula preparation instructions.

Focus groups were used to evaluate and provide recommendations to improve the reading and comprehension of powdered infant formula package preparation instructions. Five focus groups provided primary recommendations. The percentage of focus group participants reporting specific recommendations are summarized.

Outcome measures

Outcome measures
Measure
Phase 1
n=21 Participants
Up to 40 individuals will be recruited to participate in focus groups at Pennington Biomedical Research Center. Approximately six focus groups (each with 5-10 participants) will be conducted at the Pennington Biomedical Demonstration Kitchen over the course of approximately 3 months.
Phase 2
Up to 150 individuals who did not participate in Whoa Baby Phase 1 will be recruited to test the efficacy of the revised instructions on infant overfeeding in comparison with the instructions currently provided on the packaging.
Phase 2 Modified Instructions
Up to 150 individuals who did not participate in Whoa Baby Phase 1 will be recruited for Phase 2. Up to 75 individuals will be randomized to prepare infant formula using modified instructions.
Focus Group Recommendations to Improve Infant Formula Preparation Instructions
Pictures were helpful
60 percentage of focus group participants
Focus Group Recommendations to Improve Infant Formula Preparation Instructions
Clarify Safety Information
80 percentage of focus group participants
Focus Group Recommendations to Improve Infant Formula Preparation Instructions
Define and emphasize "level" and "unpacked" scoop
100 percentage of focus group participants
Focus Group Recommendations to Improve Infant Formula Preparation Instructions
Move mixing guide to the top
60 percentage of focus group participants

PRIMARY outcome

Timeframe: Day 1

Population: This outcome measure does not apply to Phase 1 participants because Phase 1 participants did not participate in the double blind, randomized controlled portion of the trial. Phase 1 participants did not prepare infant formula bottles according to either the standard or modified instructions.

Percent Error of the formula weight prepared by Phase 2 study participants as compared to the expected formula weight from the manufacturer's label. Phase 2 participants were either randomly assigned the standard instructions or the instructions that were modified as a result of the Phase 1 focus groups. Percent error was calculated as the measured formula weight prepared by Phase 2 study participants subtracted from the expected formula weight found on the manufacturer's label with that result being divided by the expected formula weight found on the manufacturer's label. The final result is multiplied by 100 to provide the percent error. Percent error is presented as opposed to formula weight because each participant prepared two 2, 4, 6, and 8 oz bottles. Percent error analysis includes all bottles prepared regardless of size.

Outcome measures

Outcome measures
Measure
Phase 1
Up to 40 individuals will be recruited to participate in focus groups at Pennington Biomedical Research Center. Approximately six focus groups (each with 5-10 participants) will be conducted at the Pennington Biomedical Demonstration Kitchen over the course of approximately 3 months.
Phase 2
n=75 Participants
Up to 150 individuals who did not participate in Whoa Baby Phase 1 will be recruited to test the efficacy of the revised instructions on infant overfeeding in comparison with the instructions currently provided on the packaging.
Phase 2 Modified Instructions
n=75 Participants
Up to 150 individuals who did not participate in Whoa Baby Phase 1 will be recruited for Phase 2. Up to 75 individuals will be randomized to prepare infant formula using modified instructions.
Percent Error of Dispensed Formula Weight as Compared to Expected Formula Weight
-4.66 percentage of error
Standard Deviation 0.74
-0.67 percentage of error
Standard Deviation 0.76

Adverse Events

Phase 1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Phase 2 Standard Instructions

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Phase 2 Modified Instructions

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Abby Altazan

Pennington Biomedical Research Center

Phone: 2257632801

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place